BERNENGO, Maria Grazia
 Distribuzione geografica
Continente #
NA - Nord America 8497
EU - Europa 8448
AS - Asia 3624
SA - Sud America 129
AF - Africa 73
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 20
Totale 20840
Nazione #
US - Stati Uniti d'America 8289
CN - Cina 2551
IT - Italia 2244
IE - Irlanda 1011
FR - Francia 883
DE - Germania 737
UA - Ucraina 676
SE - Svezia 664
FI - Finlandia 619
KR - Corea 580
AT - Austria 448
GB - Regno Unito 361
PL - Polonia 337
CA - Canada 190
VN - Vietnam 154
DK - Danimarca 98
JP - Giappone 97
IN - India 92
ES - Italia 73
BR - Brasile 68
NL - Olanda 53
SN - Senegal 50
BE - Belgio 45
AU - Australia 43
CH - Svizzera 42
TR - Turchia 39
GR - Grecia 32
CO - Colombia 23
RU - Federazione Russa 23
EU - Europa 20
NO - Norvegia 19
TW - Taiwan 18
MX - Messico 15
PT - Portogallo 15
AR - Argentina 14
RO - Romania 14
CL - Cile 12
HK - Hong Kong 12
IR - Iran 10
EG - Egitto 9
HR - Croazia 9
HU - Ungheria 8
SG - Singapore 8
TH - Thailandia 8
UZ - Uzbekistan 8
ID - Indonesia 7
MO - Macao, regione amministrativa speciale della Cina 6
MU - Mauritius 6
NZ - Nuova Zelanda 6
PE - Perù 6
RS - Serbia 6
IL - Israele 5
LV - Lettonia 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
KW - Kuwait 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
CZ - Repubblica Ceca 3
LB - Libano 3
MY - Malesia 3
SI - Slovenia 3
ZA - Sudafrica 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BY - Bielorussia 2
DZ - Algeria 2
EE - Estonia 2
JO - Giordania 2
LK - Sri Lanka 2
LT - Lituania 2
NG - Nigeria 2
PA - Panama 2
QA - Qatar 2
AM - Armenia 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
CY - Cipro 1
HN - Honduras 1
IQ - Iraq 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
NP - Nepal 1
PH - Filippine 1
SA - Arabia Saudita 1
SM - San Marino 1
UY - Uruguay 1
VE - Venezuela 1
Totale 20840
Città #
Beijing 2095
Chandler 1424
Dublin 1006
Villeurbanne 577
Houston 519
Jacksonville 518
Princeton 460
Vienna 436
Medford 435
Ann Arbor 425
Fairfield 348
Dearborn 326
Wilmington 309
Warsaw 302
Torino 289
Woodbridge 218
Ashburn 192
Redwood City 188
Milan 181
Nyköping 154
Cambridge 145
Seattle 140
Pisa 116
Boardman 109
Toronto 96
Dong Ket 86
Boston 84
Fremont 79
Verona 66
Rome 63
Shanghai 49
Falls Church 48
Nanjing 47
Lachine 44
Guangzhou 43
Norwalk 43
Brussels 38
Hefei 38
Tokyo 32
Napoli 31
Jinan 28
Chengdu 27
Kunming 27
Des Moines 23
New York 22
San Diego 21
Genova 19
Saluzzo 19
Athens 18
Madrid 17
Turin 17
Bologna 16
Florence 16
Helsinki 16
Munich 16
Mountain View 15
Nanchang 15
Phoenix 15
São Paulo 15
Brescia 14
Duncan 13
Newcastle Upon Tyne 13
Palermo 13
Radomsko 13
Padova 12
Paris 12
Redmond 12
Santiago 12
Silver Spring 12
Chicago 11
Hangzhou 11
Leiden 11
Shenyang 11
Taipei 11
Detroit 10
Hebei 10
San Mateo 10
Zhengzhou 10
Bergen 9
Columbus 9
Dallas 9
Gurgaon 9
Hazelwood 9
Nürnberg 9
Ottawa 9
San Antonio 9
Venezia 9
Bari 8
Bolzano 8
Buffalo 8
Changsha 8
Copenhagen 8
Hanoi 8
Istanbul 8
Montréal 8
Wuhan 8
Catania 7
Chongqing 7
Philadelphia 7
Prato 7
Totale 12563
Nome #
Prospective International Multicenter Phase II Trial of Intravenous Pegylated Liposomal Doxorubicin Monochemotherapy in Patients With Stage IIB, IVA, or IVB Advanced Mycosis Fungoides: Final Results From EORTC 21012. 563
Th1, Th2, Th17 and Regulatory T Cell Pattern in Psoriatic Patients: Modulation of Cytokines and Gene Targets Induced by Etanercept Treatment and Correlation with Clinical Response. 495
Malattie bollose autoimmuni: casisitica clinica e approccio terapeutico 359
Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre. 309
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study 284
Efficacia della fotochemioterapia extracorporea nel trattamento di un caso di lichen erosivo 247
Metastasi ossee da melanoma: incidenza e impatto sulla sopravvivenza 238
Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid 232
Atopic dermatitis in a phenylketonuric untreated patient 226
Clinicopathologic spectrum of cutaneous diseases in patients with hematologic malignancies with or without allogeneic bone marrow transplantation: an observational cohort study in 101 patients. 223
Effectiveness of extracorporeal photochemotherapy in the treatment of a case of refractory erosive lichen planus 221
Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome 216
Giornale italiano di Dermatologia e Venereologia 202
Functional and Phenotypical Impairment of Polymorphonuclear Cells in Atopic Dermatitis: An Additional Cause for the Known Susceptibility to Infections? [*M.T. Fierro and G. Banche contributed equally to this work] 192
Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients. 187
Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies. 178
Functional and phenotypical alterations of polymorphonuclear cells in Sézary syndrome patients [*MT. Fierro and AMC Cuffini contributed equally to this work] 177
Thymopentin down-regulates both activity and expression of iNOS in blood cells of Sézary syndrome patients 171
The inclusion complex of 4-hydroxynonenal with a polymeric derivative of Β-cyclodextrin enhances the antitumoralefficacyof the aldehyde in several tumor cell lines and in a three-dimensional human melanoma model 168
Malattia di Castleman multicentrica associata a sarcoma di Kaposi Savoia P, Fierro MT, Quaglino P, Zaccagna A, Bernengo MG 164
Effectiveness of electrochemotherapy in treatment of a recurrent squamous cell carcinoma of the scalp. 160
Alterazioni funzionali e fenotipiche dei polimorfonucleati nella sindrome di sezary 159
Expression of AP-2a, AP-2g and ESDN in primary melanomas: Correlation with histopathological features and potential prognostic value 156
Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients. 154
Relevance of multiple basin drainage and primary histologic regression in prognosis of trunk melanoma patients with negative sentinel lymph nodes. 154
High-dose immunoglobulines and extracorporeal photochemotherapy in the treatment of febrile ulceronecrotic Mucha-Habermann disease. 151
Adult-onset cutaneous mastocytosis in monozygotic twins. 145
Patologie dermatologie e rischio di neoplasia in pazienti portatori di trapianto di rene: revisione della casistica torinese 143
Long-term evolution of an untreated primary cutaneous follicle center lymphoma of the scalp 135
VENTI ANNI DI ESPERIENZA CON LA FOTOFERESI 126
Rischio di recidiva ed intervallo libero da malattia: linee guida di terapia e follow-up. 123
Halo nevi related to treatment with imatinib in a dermatofibrosarcoma protuberans patient 112
Epstein-Barr virus in cutaneous T-cell lymphomas: evaluation of the viral presence and significance in skin and peripheral blood 111
Prognostic differences across sexes in melanoma patients: What has changed from the past? 110
Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: A single centre observational cohort study. 101
L'elettrochemioterapia nel trattamento del sarcoma di Kaposi: l'esperienza di Roma e Torino 100
Fotoferesi: applicazioni terapeutiche “off-label” 98
Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome). 97
Alterazioni funzionali e fenotipiche dei polimorfonucleati nei pazienti affetti da dermatite atopica 97
BANS: a discussion of the problem. 95
Multiple pyogenic granuloma of the penis. 94
[Activity of deoxycytidylate-deaminase in human lymphocytes stimulated with phytohemagglutinin] 92
A retrospective analysis of the costs and management of genital warts in Italy. 92
Functional properties in Sézary cells with an unusual phenotype. 91
Favourable prognostic role of regression of primary melanoma in AJCC stage I-II patients. 90
Manifestazioni cutanee correlate al trattamento con imatinib mesilato in pazienti affetti da dermatofibrosarcoma protuberans 89
Detection of HIV p24 from antigen presenting monocytes for early diagnosis of HIV-1 infection. 88
Alemtuzumab for the treatment of Sézary sindrome: clinical and immunological findings in 10 patients. 88
microRNA-214 promotes melanoma tumor progression 87
[Pemphigus-pemphigoid mixed bullous dermatosis in chronic lymphatic leukemia] 86
Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models 86
A case of acute promyelocytic leukaemia with bullous, haemorrhagic and necrotic skin lesions. 85
Active rosette test in cutaneous lymphoproliferative disorders. 83
Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients. 83
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 83
[Cutaneous melanoma at the Turin Melanoma Center. I. Survival and correlation with clinical and histologic prognostic factors in 502 patients in stage I (1975-1985)] 82
Micosi fungoide: dall'istopatologia alla biologia molecolare 82
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 80
VEGF-165 serum levels and tyrosinase expression in melanoma patients: correlation with the clinical course. 80
[Serum levels of soluble receptors of interleukin-2 in skin pathology] 79
EPILUMINESCENZA DIGITALE NEI MELANOMI SOTTILI: CORRELAZIONI CON I PARAMETRI CLINICO-PATOLOGICI 79
Melanoma maligno della congiuntiva con infiltrazione sclerale e metastasi mediastiniche: case report 78
Changes in T and B lymphocyte subpopulations before, during and after chemotherapy for malignant melanoma. 78
T-cell subsets in melanoma patients evaluated by anti-T-cell monoclonal antibodies. 77
[Cutaneous melanoma at the Turin Melanoma Center. II. Risk of metastasis and free interval in relation to the clinical and histological prognostic factors in 502 patients in stage I (1975-1985)] 77
Metastasi precoci e tardive nel melanoma. 77
Human herpesvirus 7 detection by quantitative real time polymerase chain reaction in primary cutaneous T-cell lymphomas and healthy subjects: lack of a pathogenic role 77
Peripheral blood involvement in a mycosis fungoides patient with limited skin lesions: phenotypical features and homing molecule pattern 77
Improvement of sensitivity in sentinel lymph node procedure in melanoma patients. 76
Prevention of recurrences in frequently relapsing herpes labialis with thymopentin. A randomized double-blind placebo-controlled multicenter study. 76
Immunomodulation and Sézary syndrome: experience with thymopentin (TP-5). 76
Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients. 76
Endothelial and Smooth muscle cell Derived Neuropin-like molecule and AP-2 family protein expression in primary melanoma predicts Disease Free Survival in melanoma patients 76
Phase II trial of recombinant alpha-2b interferon in the treatment of metastatic skin melanoma. 72
The in vitro effect of a calf thymus extract on the peripheral blood lymphocytes of sixty-six melanoma patients. 72
Natural killer cells and lymphomatoid granulomatosis. 72
Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells 72
Leucosis and skin: acute lymphoid immunoblastic leukaemia. 71
The prognostic value of T-lymphocyte levels in malignant melanoma. A five-year follow-up. 71
The in vitro effect of a calf thymus extract on the peripheral blood lymphocytes of patients with warts. 71
Traditional urinary cytology and tyrosinase RT-PCR in metastatic melanoma patients: correlation with clinical status 70
Chronic T-cell leukaemias. III. T-colonies, PHA response and correlation with membrane phenotype. 69
[Pemphigus induced by monoclonal IgM with anti-IgG antibody activity in a case of Waldenström's 's 's macroglobulinemia] 69
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. 69
[Effect of methotrexate on DNA synthesis in human lymphocytes stimulated with phytohemagglutinin] 68
Adhesion molecules in lymphomatoid granulomatosis 68
Associazione di ciclofosfamide, vincristina e prednisone (COP) nel trattamento dei linfomi cutanei: 20 anni di follow-up. 68
[Heterogenicity of T-cell cutaneous lymphomas: pleomorphic lymphoma of intermediate phenotype between the thymic and post-thymic stages. Study of 2 cases] 67
Guess what? Inflammatory disseminated morphea profunda. 67
Metastasi cutanee da melanoma ad aspett ozosteriforme: report di un caso e revisione della letteratura 67
Linfociti Treg e fotoferesi 66
Relationship between T and B lymphocyte values and prognosis in malignant melanoma. 65
Skin lesions in angioimmunoblastic lymphadenopathy: histological and immunological studies. 65
Low-dose intermittent Alemtuzumab in Sézary Syndrome: clinical activity, toxicity profile and immunological findings in 17 patients. 65
Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patients. 65
Aggressive subtypes of cutaneous T-cell lymphoma subsets: management and prognosis. 64
Clonal heterogeneity in mycosis fungoides/Sézary Syndrome: incidence, relation with clinico-pathologic features and prognostic significance 64
Collagenase digestion and mechanical disaggregation as a method to extract and immunophenotype tumour lymphocytes in cutaneous T-cell lymphomas. 64
Deoxycytidylate deaminase activity and its template stability in human acute lymphoblastic and myeloblastic leukaemic cells. 64
Cutaneous manifestations in T-zone lymphoma. 63
Totale 12127
Categoria #
all - tutte 33335
article - articoli 0
book - libri 0
conference - conferenze 11783
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45118


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20183632 0000 00 0715 212660274115
2018/20192473 12788260108 105184 143346 139236487250
2019/20203445 139139217366 296555 432248 354274222203
2020/20212426 398137186137 204157 18293 250232191259
2021/20222506 6392138136 150106 162123 86130483837
2022/20233421 626274105350 4941114 4562 0000
Totale 21791